Sun Pharmaceutical Industries Limited informed that the Meeting of the Board of Directors of the Company was held on November 01, 2022. The Board of Directors approved the appointment of Mr. Sanjay Asher (DIN: 00008221), as an Additional Director designated as an Independent Director of the Company for a term commencing from November 01, 2022 till March 31, 2025, subject To Approve the shareholders. Mr. Sanjay Asher is presently a Senior Partner with M/s. Crawford Bayley & Co., which is India's oldest law firm, established in 1830.

Mr. Asher holds a Bachelor's Degree in Commerce and a Bachelor's Degree in Law from the University of Bombay. He has been a practicing Advocate since 1991, and was admitted as a Solicitor in the year 1993. He is also a qualified Chartered Accountant.

He specialises in the fields of M&A, cross border M&A, joint ventures, private equity and capital markets. He has been a noted speaker at various seminars and conferences including those organised by Institute of Chartered Accountants of India, Institute of Company Secretaries of India. He has authored several publication published in national and international publications including authored a book on Companies Act, 2013 which was published by CCH, a Wolters Kluwer publication.